Down-regulation of hepatic and renal 11β-hydroxysteroid dehydrogenase in rats with liver cirrhosis

Gastroenterology

Volumn 114, Issue 1, 1998, Pages 175-184

  Escher, G ^a   Nawrocki, A ^a   Staub, T ^a   Vishwanath, B S ^a   Frey, B M ^a   Reichen, J ^a   Frey, F J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTICOSTERONE; DEHYDROCORTICOSTERONE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CONTROLLED STUDY; ENZYME REGULATION; INHIBITION KINETICS; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION ANALYSIS; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM;

EID: 0031973313     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70645-6     Document Type: Article

References (57)

1. FJ Frey Kinetics and dynamics of prednisolone Endocr Rev 8 1987 453 473
2. JW Funder PT Pearce R Smith AI Smith Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated Science 243 1988 583 585
3. CRW Edwards PM Stewart D Burt L Brett MA McIntyre WS Sutano ER de Kloet C Monder Localisation of 11β-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor Lancet 2 1988 986 989
4. G Escher FJ Frey BM Frey 11β-hydroxysteroid dehydrogenase accounts for low prednisolone/prednisone ratios in the kidney Endocrinology 135 1994 101 106
5. AK Agarwal C Monder B Eckstein PC White Cloning and expression of rat cDNA encoding corticosteroid 11β-hydroxysteroid dehydrogenase J Biol Chem 264 1989 18939 18943
6. AL Albitson VR Obeyesekere RE Smith Z Krozowski Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme Mol Cell Endocrinol 105 1994 R11 R17
7. E Rusvai A Naray-Fejes-Toth A new isoform of 11β-hydroxysteroid dehydrogenase in aldosterone target cells J Biol Chem 268 1993 10717 10720
8. PM Stewart CB Whorwood 11β-hydroxysteroid dehydrogenase activity and corticosteroid hormone action Steroids 59 1994 90 95
9. RW Schrier Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy N Engl J Med 319 1988 1127 1138
10. M Levy MJ Wexler Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity J Lab Clin Med 91 1978 520 536
11. M Levy JB Allotey Temporal relationships between urinary salt retention and altered systemic hemodynamics in dogs with experimental cirrhosis J Lab Clin Med 92 1978 560 569
12. G Wensing R Sabra RA Branch The onset of sodium retention in experimental cirrhosis in rats is related to a critical threshold of liver function Hepatology 11 1990 779 786
13. W Jiménez A Martinez-Pardo V Arroyo B Jordi A Rimola J Gaya F Rivera J Rodés Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis Hepatology 5 1985 245 250
14. JM Lopez-Novoa MA Rengel L Hernando Sodium excretion after bilateral adrenalectomy in rats with experimental cirrhosis Experientia 34 1978 1613 1614
15. M Bernardi C DiMarco F Trevisani L Fornalè P Andreone C Cursaro M Baraldini A Ligabue MR Tamè G Gasbarrini Renal sodium retention during upright posture in preascitic cirrhosis Gastroenterology 105 1993 188 193
16. PM Stewart P Burra CH Shackleton MC Sheppard E Elwyn 11β-hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease J Clin Endocrinol Metab 76 1993 748 751
17. K Tjandra P Kubes K Rioux MG Swain Endogenous glucocorticoids inhibit neutrophil recruitment to inflammatory sites in cholestatic rats Am J Physiol 270 1996 G821 G825
18. G Escher KV Meyer BS Vishwanath BM Frey FJ Frey Furosemide inhibits 11β-hydroxysteroid dehydrogenase in vitro and in vivo Endocrinology 136 1995 1944 1947
19. 2 activity in rats J Clin Invest 98 1996 365 371
20. JB Gross J Reichen T Zeltner A Zimmermann The evolution of changes in quantitative liver function tests in a rat model of cirrhosis: correlation with morphometric measurement of hepatocyte mass Hepatology 7 1987 457 463
21. V Lakshmi C Monder Evidence for independent 11-oxidase and 11-reductase activity of 11β-hydroxysteroid dehydrogenase: enzyme latency, phase transitions, and lipid requirements Endocrinology 116 1985 552 560
22. BR Cullen Use of eukaryotic expression technology in the functional analysis of cloned genes SL Berger AR Kimmel Guide to molecular cloning techniques 1987 Academic San Diego, CA 684 704
23. RE Smith KXZ Li RK Andrews Z Krozowski Immunohistochemical and molecular characterization of the rat 11β-hydroxysteroid dehydrogenase type II enzyme Endocrinology 138 1997 540 547
24. + exchange is activated at transcriptional and posttranscriptional level in rat biliary cirrhosis Gastroenterology 107 1994 468 478
25. +-antiporter mRNA in biliary epithelial cells and in hepatocytes J Hepatol 24 1996 498 502
26. AK Agarwal MT Tusie-Luna C Monder PC White Expression of 11β-hydroxysteroid dehydrogenase using recombinant Vaccina virus Mol Endocrinol 4 1990 1827 1832
27. G Escher I Galli BS Vishwanath BM Frey FJ Frey Tumor necrosis factor α and interleukin 1β enhance the cortisone/cortisol shuttle J Exp Med 186 1997 189 198
28. H Prytz J Holst-Christensen B Korner H Liehr Portal venous and systemic endotoxemia in patients without liver disease and systemic endotoxemia in patients with cirrhosis Scand J Gastroenterol 11 1976 857 863
29. C Clemente J Bosch J Rodes V Arroyo A Mas S Maragall Functional renal failure and hemorrhagic gastritis associated with endotoxemia in cirrhosis Gut 18 1977 556 560
30. LJ Wood D Massie AJ McLean FJ Dudley Renal sodium retention in cirrhosis: tubular site and relation to hepatic dysfunction Hepatology 8 1988 831 836
31. F Wong P Liu Y Allidina L Blendis Pattern of sodium handling and its consequences in patients with preascitic cirrhosis Gastroenterology 108 1995 1820 1827
32. D Oguey U Marti J Reichen Epidermal growth factor receptor: its possible implication in the maintenance of hepatocellular mass in biliary cirrhosis in the rat Eur J Cell Biol 59 1992 187 195
33. S Dueland J Reichen GT Everson RA Davis Regulation of cholesterol and bile acid homeostasis in bile obstructed rats Biochem J 280 1991 373 377
34. J Kontouras S McKavanagh M Burmicky BH Billing The effect of secretin on bile flow and bile acid and bilirubin excretion following relief of prolonged bile duct obstruction in the rat J Hepatol 4 1987 198 205
35. S Islam RE Poupon JC Barbare Y Chretien F Darnis Fasting serum bile acid level in cirrhosis. A semi-quantitative index of hepatic function J Hepatol 1 1985 609 617
36. GA Mannes C Thieme F Stellaard T Wang T Sauerbruch G Paumgartner Prognostic significance of serum bile acids in cirrhosis Hepatology 6 1986 50 53
37. SA Azer M Murray GC Farrell NH Stacey Selectivity and sensitivity of changes in serum bile acids during induction of cirrhosis in rats Hepatology 18 1993 1224 1231
38. EM Sternberg JM Hill GP Chrousos T Kamilaris SJ Listwak PW Gold RL Wilder Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats Proc Natl Acad Sci USA 86 1989 2374 2378
39. VI Sternberg MG Bouley BM Katz KJ Lee SS Parmar Negative endocrine control system for inflammation in rats Agents Actions 29 1990 189 195
40. MG Swain M Maric Prevention of immune-mediated arthritis in cholestatic rats: involvement of endogenous glucocorticoids Gastroenterology 107 1994 1469 1474
41. MG Swain K Tjandra S Kanwar P Kubes Neutrophil adhesion is impaired in a rat model of cholestasis Gastroenterology 109 1995 923 932
42. CP Armstrong JM Dixon TV Taylor GC Davies Surgical experience of deeply jaundiced patients with bile duct obstruction Br J Surg 71 1984 234 238
43. SC Low SN Assaad V Rajan KE Chapman CR Edwards JR Seckl Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney J Endocrinol 139 1993 27 35
44. JT Norman D Hardy Post-transcriptional regulation of gene expression in compensatory renal hypertrophy Exp Nephrol 2 1994 30 39
45. E Renner FF Horber G Jost BM Frey FJ Frey Effect of liver function on the metabolism of prednisone and prednisolone in humans Gastroenterology 90 1986 819 828
46. H Bühler N Kobayashi I Lichtenstein FH Perschel H Siebe K Hierholzer Reversible inhibition of renal 11β-hydroxysteroid dehydrogenase (11β-HSD) by steroids, structure-function-relationship (abstr) Nieren-Hochdruckkr 19 1990 374
47. K Hierholzer H Siebe M Fromm Inhibition of 11β-hydroxysteroid dehydrogenase and its effect on epithelial sodium transport Kidney Int 38 1990 673 678
48. C Monder PM Stewart V Lakshmi R Valentino D Burt CRW Edwards Licorice inhibits corticosteroid 11β dehydrogenase of rat kidney and liver: in vivo and in vitro studies Endocrinology 125 1989 1046 1053
49. FH Perschel H Bühler K Hierholzer Bile acids and their amidates inhibit 11β-hydroxysteroid dehydrogenase obtained from rat kidney Eur J Physiol 418 1991 538 543
50. DM Heuman WM Pandank PB Hylemon ZR Vlahcevic Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes Hepatology 14 1991 920 926
51. J Schölmerich MS Becher KH Schmidt R Schubert B Kremer S Feldhaus W Gerok Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties—studies on isolated hepatocytes and lipid membrane vesicles Hepatology 4 1984 661 666
52. AF Hofmann Bile acids IM Arias JL Boyer N Fausto WB Jakoby D Schachter DA Shafritz The liver. Biology and pathobiology 1984 Raven New York 677 718
53. L Lindblad K Lundholm T Schersten Bile acid concentrations in systemic and portal serum in presumably normal man and in cholestatic and cirrhotic conditions Scand J Gastroenterol 12 1977 395 400
54. R Ferraris T Fiorentini G Galatola P Rolfo M DeLaPierre Diagnostic value of serum immunoreactive conjugated cholic or chenodeoxycholic acids in detecting hepatobiliary diseases. Comparisons with levels of 3-alpha-hydroxy bile acids determined enzymatically and with routine liver tests Dig Dis Sci 32 1987 817 823
55. DM Collins A van Tongeren HB Cook C Campbell Serum bile acids and routine liver function tests in patients with chronic liver disease and cholestasis N Z Med J 89 1979 432 434
56. A Bremmelgaard B Alme Analysis of plasma bile acid profiles in patients with liver disease associated with cholestasis Scand J Gastroenterol 15 1980 593 600
57. R Galeazzi NB Javitt Bile acid excretion: the alternative pathway in the hamster J Clin Invest 60 1977 693 701